MATSUDA Masahide
- Articles
- Early Postoperative Expansion of Parenchymal High-intensity Areas on T2-weighted Imaging Predicts Delayed Cerebral Edema Caused by Carmustine Wafer Implantation in Patients with High-grade Glioma
MASUDA Yosuke; ISHIKAWA Eiichi; YAMAMOTO Tetsuya; MATS...
MRMS/15(3)/pp.299-307, 2015 - Profile Analysis of Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study
MATSUDA Masahide; YAMAMOTO Tetsuya; ISHIKAWA Eiichi; N...
Neurol. Med. Chir.(Tokyo)/55(9)/pp.749-755, 2015-09 - Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
Ishikawa Eiichi; Muragaki Yoshihiro; Yamamoto Tetsuya; ...
JOURNAL OF NEUROSURGERY/121(3)/pp.543-553, 2014-09 - Bevacizumab in Japanese Patients With Malignant Glioma:from basic research to clinical trial. :
Takano S; Ishikawa E; Nakai K; Matsuda M; Masumoto T; Yam...
Onco Targets and Therapy 7/7(7)/pp.1551-1562, 2014 - Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon
Tanaka Masahiko; Shimbo Takashi; Kikuchi Yasushi; Matsuda Ma...
INTERNATIONAL JOURNAL OF CANCER/126(8)/pp.1982-1991, 2010-04
- Early Postoperative Expansion of Parenchymal High-intensity Areas on T2-weighted Imaging Predicts Delayed Cerebral Edema Caused by Carmustine Wafer Implantation in Patients with High-grade Glioma